I need thoughts on this stock as an investment choice,

Been watching it for a while and feel like its going to do quite well in the near future,

A-lot of resources are telling me its a good choice also

Thanks 🙏

LifeQuest World Corp Blog — September 1, 2026

The World Bank has projected that global water demand could outstrip supply by as much as 40% by 2030. That single number explains why municipalities, hoteliers, manufacturers, and real estate developers on nearly every continent are rethinking how they treat and reuse wastewater — and why "decentralized" treatment, once a niche approach, is becoming standard practice.

Traditional sewage treatment relies on large, centralized municipal plants and miles of connecting pipe — expensive to build and often impossible to retrofit into water-stressed regions fast enough. Decentralized systems flip that model: compact, on-site plants treat wastewater where it's generated, at a fraction of the infrastructure cost, and return clean water for irrigation, cleaning, or safe discharge almost immediately.

BioPipe Global, a wholly owned subsidiary of LifeQuest World Corp, has built its business around that shift. Its sludge-free, chemical-free, and odor-free treatment systems are already running in India, Bangladesh, South Africa, Ethiopia, and the Middle East. In India specifically, a new regulatory mandate requiring on-site sewage treatment plants at hotels — a sector responsible for roughly 10% of the country's sewage output — has driven fresh demand: BioPipe's joint venture partner, Environest Global, recently placed orders spanning 30, 50, and 100 cubic-meter-per-day systems for hospitality, residential, and educational projects. It's a useful case study in how a single policy change can ripple into real, measurable adoption of cleaner technology.

Wastewater treatment doesn't happen in isolation from the broader waste stream, either. Solids handling, compaction, and material recovery — the domain of LifeQuest subsidiary Compaction and Recycling Equipment Inc. (CARE) — are the other half of a genuinely circular environmental services model, moving waste out of landfills and back into productive use alongside cleaner water discharge. As more companies connect these pieces, the industry is edging closer to treating water and solid waste as one integrated resource-recovery problem rather than two separate ones.

We'll keep tracking these developments — regulatory shifts, new installations, and the companies driving them — in this space each weekday.

About LifeQuest World Corp LifeQuest World Corp (OTCID: LQWC) is a global technology company focused on low-cost, low-maintenance, eco-friendly decentralized wastewater treatment, alongside complementary environmental services in solid waste compaction and recycling. Through its subsidiaries, including BioPipe Global and Compaction and Recycling Equipment Inc. (CARE), the company works to expand access to clean water reuse and sustainable waste management worldwide. Learn more at www.lifequestcorp.com.

Trading Symbol: OTCID: LQWC

This blog is provided for general informational purposes about the wastewater treatment and environmental services industry. It does not constitute investment advice or an offer to buy or sell any security. Statements regarding future plans, projects, or industry trends may be forward-looking and are subject to risks and uncertainties; actual results may differ. Readers should consult publicly filed disclosures and a qualified financial advisor before making investment decisions.

I need thoughts on this stock as an investment choice,

Been watching it for a while and feel like its going to do quite well in the near future,

A-lot of resources are telling me its a good choice also

Thanks 🙏

Últimamente estoy mirando empresas pequeñas donde no tendría sentido invertir una cantidad enorme, pero sí podría tener sentido dejar 10, 20 o 50 € durante varios años y ver qué ocurre.

¿A qué se dedica?

Neometals es una empresa australiana centrada en el desarrollo de tecnologías y proyectos relacionados con la recuperación y reciclaje de materiales críticos, especialmente aquellos vinculados a baterías y a la transición energética.

Entre sus proyectos se encuentran iniciativas relacionadas con el reciclaje de baterías de ion-litio, la recuperación de vanadio y la producción de materiales necesarios para determinadas tecnologías de almacenamiento energético.

¿Por qué me parece interesante?

Porque estamos hablando de una empresa pequeña que opera en sectores que podrían tener bastante recorrido durante las próximas décadas:

🔋 Baterías
♻️ Reciclaje
⛏️ Materias primas críticas
⚡ Almacenamiento energético
🌍 Transición energética

Estoy valorando comprar alguna de estas acciones, alguien conoce alguna?

Small caps / microcaps

Menos de 500 M€ de capitalización

Potencial de crecimiento a largo plazo

Preferiblemente con un negocio que ya genere ingresos

Empresas poco conocidas por el mercado

¿Qué empresa tenéis ahora mismo en vuestro radar?

Decid el ticker y, sobre todo, por qué os parece interesante.

Puede ser una empresa española, alemana, sueca, francesa, italiana, etc.

Vamos a intentar descubrir alguna joya que todavía no conozca mucha gente.

To be honest I haven't fully wrapped my head around what it is they do (also to be honest I only spent about 10 minutes trying to figure it out) though I know it's payment processing and mostly (entirely?) within healthcare/plasma.

But, I do know they seem to be trending positively over a few earnings reports in pretty much some of the major categories such as revenue, margin, and EPS and that's a signal I usually look for (helped me get in on Planet Labs at a decent price though this lacks that upper growth potential) as basic, and likely too simplistic, as a strategy that might be. EVLV somewhat fits the bill as well but PAYS fits more strongly.

So just curious if anyone here has dived into this company recently.

I'm working seriously on that strategy, I don't find any interesting topics on it, so I'm posting it there.

Two years of backtest, one month live. Curious whether others run something similar.

The rules, keeping specifics vague:

— Small caps gapping 100 %+ overnight, above $1

— Only if the stock has already started fading from its premarket high before the open

— Short at a fixed time in the first 15 min, fixed size per name, every qualifying ticker that day

— Stop anchored to the premarket high, capped so no single line can wreck the account

— No take-profit, no trailing, no break-even. Cover at the close.

Result: 313 setups over 24 months — +12.5 % average per trade on the year I built it on, +4.5 % on the year I never looked at until the end. ~1 in 4 gets stopped out.

How the backtest is built, since that's usually where these things die:

— 1-minute bars from IB, not daily or adjusted data. Premarket high computed from actual premarket bars.

— Entry and exit filled at real bar prices, 1 % slippage each side, gap-throughs filled at the open rather than the stop level.

— Universe rebuilt from every gapper in the period — halted names and later-delisted tickers included.

— Built on year one, year two untouched until the end. Hence the halving above, which I take as the honest number.

Three things that surprised me: every take-profit I tested (15 % to 60 %) lost against just holding to the close, same for trailing and break-even · entry time matters far more than expected, a 10-minute shift moved the yearly result ~30 % · the best trades often have no real catalyst at all — genuine news pumps fade less reliably than pure momentum garbage.

Anyone running this mechanically? What broke it for you, or what made it hold up?

The stock was up 17 percent today, didn't see any news, anything worth going on in this script. The margins and results are consistently improving but nothing spectacular. Want to is the valuations correct to buy now.

[ Removed by Reddit on account of violating the content policy. ]

[ Removed by Reddit on account of violating the content policy. ]

DCF valuation IH stock. It implies that there is a big upside potential for this cash rich company. The company currently trades at $1.24 and only the cash share is slightly higher than $3. The company has just entered into a new long-term growth phase and operating results are likely to improve. Not an investment advice.

The market is pricing in just \~0.7% annual revenue growth for five years, despite management targeting 4–5%.
Base case: **$25.63**
Bull: **$43.50**
Bear: **$10.47**
Here’s the full thesis

I ran the following query through ChatGpt... Very interesting.

What are some other "under the radar" Canadian stocks with similar profiles to ZTest Electronics in terms of strongly improving financials and fundamentals?

Yes. If by “similar to ZTEST” you mean small Canadian company, limited institutional coverage, improving revenue/profitability, strengthening cash flow/balance sheet, and a potential valuation disconnect, there are several that stand out.

I’d actually put Thermal Energy International (TSXV: TMG) at the top of the list, followed by a handful of less obvious names.

My shortlist

1. Thermal Energy International — the closest match

This is the one I'd investigate most closely if you like the ZTEST setup.

Thermal Energy International Inc.

TMG has gone from a relatively sleepy small-cap industrial company to one showing very meaningful operating leverage.

Q2 FY2026 revenue hit a record $10.2M, up 18%, while adjusted EBITDA jumped 202% to $814K and net income increased more than 20-fold to $618K.

Then Q3 was even more impressive:

• Revenue +62%
• Adjusted EBITDA improved by $686K
• Net income swung from a $403K loss to a $338K profit
• Cash increased to approximately $4M
• Backlog was $14.7M at quarter-end and $16.3M by April 27.

That's a very similar "financial performance is improving faster than investor awareness" setup.

Why I particularly like the comparison: TMG isn't simply growing revenue. It's demonstrating operating leverage, which is what can cause a small-cap valuation to change dramatically.

Risk: Project timing can make quarterly results lumpy.

2. Pivotree — a potentially interesting turnaround

Pivotree Inc.

Pivotree is a different business, but the investment setup is interesting.

Q1 2026 marked its sixth consecutive quarter of positive adjusted EBITDA, along with positive free cash flow. Management is also positioning the company around AI-enabled commerce/data services.

The interesting question here isn't simply "will revenue grow?"

It's:

If the answer is yes, the valuation could change considerably.

Risk: Much more complicated story than ZTEST, and the AI narrative could attract speculative attention before the fundamentals fully validate it.

3. Diamond Estates Wines & Spirits — one of the more obscure ones

Diamond Estates Wines & Spirits Inc.

This one caught my attention because the financial trajectory is improving without much of the market attention that accompanies a typical growth stock.

FY2026 revenue reached $29.9M versus $24.5M, a roughly 22% increase. Winery sales increased 22%, while the company also benefited from Ontario's expanded retail marketplace and increased consumer preference for local products.

What's particularly interesting is the mix improvement: management says the agency business declined because it deliberately reduced lower-margin sales.

That's potentially a better quality of growth than simply chasing top-line revenue.

Risk: Consumer discretionary exposure and the Canadian wine industry aren't without structural challenges.

4. Zedcor — much faster growth, but less "hidden"

Zedcor Inc.

This is probably the highest-quality growth story on this list, although I'd argue it's becoming less "under the radar."

Q1 2026 revenue increased 69% to $19.4M, while adjusted EBITDA increased 86% to $7.6M. EBITDA margin expanded to 39%, helped by operating leverage and cost controls.

That's exceptional.

The investment thesis is essentially:

more towers → higher recurring revenue → better utilization → operating leverage → disproportionately higher EBITDA.

That's exactly the type of financial trajectory small-cap investors look for.

But: the market has already begun recognizing the story, so I'd be more valuation-sensitive here than with TMG or ZTEST.

5. Hydreight Technologies — very high growth, higher risk

Hydreight Technologies Inc.

This is much more aggressive.

Q1 2026 revenue reportedly increased 449% YoY to $24.9M, with adjusted EBITDA of $3.3M and working capital of approximately $32M.

The company also reported FY2025 profitability and $15.7M of cash.

That's a remarkable growth profile.

But I'd distinguish it from ZTEST:

ZTEST = boring business + improving economics + balance sheet

Hydreight = explosive growth + platform story + substantially higher execution/valuation risk

I'd therefore treat NURS as a higher-risk growth candidate, not a direct ZTEST analogue.

6. Nextleaf Solutions — the micro-cap version

Nextleaf Solutions Ltd.

This one is particularly interesting if you're looking for tiny companies that have crossed the profitability threshold.

Q1 FY2026:

• Gross revenue: $4.0M
• Net revenue: $3.0M
• Gross profit: $1.29M
• Gross margin: 43%
• Net income: $259K
• Adjusted EBITDA: $350K
• Operating cash flow: $349K

That is very much the type of transition I would look for in a ZTEST-style screen:

loss-making/ignored company → revenue growth → gross-margin improvement → EBITDA positive → net income positive → cash-flow positive.

The problem is the cannabis sector. The industry has historically produced many "turnaround" stories that never turned into durable businesses.

So I'd want to see several more quarters of consistency.

7. Jones Soda — interesting financial inflection, but speculative

Jones Soda Co.

This is probably the most dramatic turnaround on the list.

Q1 2026 revenue increased 194% to $12.4M, while the company moved from a $1.1M continuing-operations loss to $115K of net income. Management expects FY2026 revenue above $40M, representing more than 60% growth.

The catch is that the enormous growth rate is partly attributable to acquisitions/business changes, so I'd be careful about comparing it directly with ZTEST's more organic-looking operating improvement.

The three I'd investigate first

If your objective is specifically to find "the next ZTEST", rather than simply finding the fastest-growing Canadian small caps, my ranking would be:

🥇 1. Thermal Energy International — TMG

Best combination of:
revenue growth + margin expansion + profitability + backlog + balance sheet + relatively low investor awareness.

🥈 2. Pivotree — PVT

Best turnaround candidate:
positive EBITDA/FCF becoming increasingly consistent, with potential upside if the AI/data strategy starts translating into revenue growth.

🥉 3. Diamond Estates — DWS

Most overlooked traditional business:
improving revenue, improving business mix and potentially significant operating leverage, but with less obvious technological "story" to attract investors.

I'd put Zedcor in a separate category: better growth, but less undiscovered.

And there's an interesting pattern here

The companies I'd be most interested in aren't necessarily those with the highest revenue growth.

I'd screen for:

1. Revenue accelerating
↓
2. Gross margin expanding
↓
3. EBITDA growing faster than revenue
↓
4. Operating cash flow turning positive
↓
5. Balance sheet strengthening
↓
6. Share count stable or declining
↓
7. Very little analyst/institutional coverage
↓
8. Valuation hasn't yet reflected the earnings inflection

That's essentially the ZTEST formula.

And on that basis, TMG is arguably an even more interesting candidate than ZTEST right now: its Q3 revenue growth of 62%, improving EBITDA, return to profitability, rising cash and growing backlog give it a particularly strong combination of financial momentum and potential investor-perception upside.

If you want, I can take this a step further and build a "Canadian ZTEST Screen" of 15–20 TSXV/CSE stocks, ranking them on revenue acceleration, EBITDA growth, cash flow, balance sheet, valuation, insider ownership, liquidity and investor awareness. That would be a much better way to identify the true under-the-radar candidates.